Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Using machine learning, researchers find patterns in electronic health record data to better identify those likely to have the condition.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.
National Comprehensive Cancer Network encourages second mRNA booster shot and offers COVID PrEP advice for people with cancer.
A federal court judge in Florida said the Centers for Disease Control and Prevention had overstepped its authority.
Remdesivir (Veklury) is now approved for kids ages 28 days to 12 years.
New laws make it easier for people to see their loved ones in health care facilities during the pandemic.
Paxlovid and molnupiravir can reduce the risk of severe COVID-19, but they must be started within five days of symptom onset.
The diagnostic test can provide results in less than three minutes.
Though such cases may not always amount to debilitating long COVID, it is common to take weeks to fully recover.
The United States might see one of the steepest increases in the country’s uninsured rate in years.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
Could the immune dysfunction that causes severe COVID in people with schizophrenia be what drives their psychotic symptoms?
The quick spread of the BA.2 subvariant is likely due to its greater infectiousness rather than its ability to evade the immune system.
NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.
While vaccination typically provides robust protection against severe disease, they’re less effective for immunocompromised people.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.